Skip to content

RNTX RNTX Shares (Basic)

Shares (Basic) at other companies

Gilead Sciences logo
Gilead SciencesGILD
1.2B-0.3%
AbbVie logo
AbbVieABBV
1.8B+0.1%
CTO
Citius Oncology, Inc.CTOR
100M+39.8%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
98M+13.4%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
91.3M+5.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's shares (basic)?
RNTX (RNTX) reported shares (basic) of 30.4M in Q1 2026.
How has RNTX's shares (basic) changed year-over-year?
RNTX's shares (basic) increased by 38.5% year-over-year, from 21.9M to 30.4M.
What is the long-term trend for RNTX's shares (basic)?
Over 3 years (2022 to 2025), RNTX's shares (basic) has grown at a 75.4% compound annual growth rate (CAGR), from 18.2M to 97.9M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.